Tenet Healthcare Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Tenet Healthcare stock has a consensus rating of "Buy" and an average price target of $285.1. The average 1-year stock price forecast is 10.05% higher than the current stock price, while the lowest is $260 (+0.36%) and the highest is $315 (+21.59%).

Price Target: $285.1 (+10.05%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$260	$285.1	$285	$315
Change	+0.36%	+10.05%	+10.01%	+21.59%

Analyst Ratings

The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	14	14	14	14	14	14
Buy	6	6	6	6	5	5
Hold	2	2	2	2	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	22	22	22	22	22	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Benjamin Rossi J.P. Morgan	J.P. Morgan	Buy Maintains $315	Buy	Maintains	$315	+21.59%	Sep 2, 2026
A.J. Rice UBS	UBS	Buy Maintains $308	Buy	Maintains	$308	+18.89%	Aug 25, 2026
Ann Hynes Mizuho Securities	Mizuho Securities	Buy Maintains $250 → $290	Buy	Maintains	$250 → $290	+11.94%	Aug 10, 2026
Kevin Fischbeck Bank of America Securities	Bank of America Securities	Buy Reiterates $290 → $295	Buy	Reiterates	$290 → $295	+13.87%	Aug 10, 2026
Stephen Baxter Wells Fargo	Wells Fargo	Buy Reiterates $231 → $281	Buy	Reiterates	$231 → $281	+8.47%	Jul 31, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

22.44B

from 21.31B

5.31%

from 21.31B

Revenue Next Year

22.53B

from 22.44B

0.38%

from 22.44B

EPS This Year

21.22

from 16.78

26.49%

from 16.78

EPS Next Year

21.08

from 21.22

-0.67%

from 21.22

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	19.49B	19.17B	20.56B	20.68B	21.31B	22.44B
Revenue Growth	10.46%	-1.60%	7.25%	0.54%	3.07%	5.31%
Gross Profit	7.27B	7.05B	7.82B	8.22B	8.82B	10.70B
Gross Margin	37.30%	36.76%	38.03%	39.75%	41.37%	47.70%
Operating Income	2.56B	2.49B	2.81B	3.22B	3.77B	4.26B
Net Income	914.00M	411.00M	611.00M	3.20B	1.41B	2.80B
EPS	-	-	-	-	16.78	21.22
EPS Growth	-	-	-	-	41.25%	26.49%
Forward PE	13.95	9.55	13.40	11.76	12.20	12.21
Free Cash Flow	1.56B	103.88M	903.00M	2.33B	1.68B	2.98B
No. Analysts	-	-	-	-	-	19

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	24.3B
Avg	22.4B
Low	22.1B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	13.8%
Avg	5.3%
Low	3.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	21.65
Avg	21.22
Low	20.66

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	29.0%
Avg	26.5%
Low	23.1%